Go

Eye Birth Defects Institute

Print Page A A A

Dr. Mark S. Borchert

Director, Eye Birth Defects Institute
Director, Eye Technology Institute

Read His Bio
Meet the Eye Birth Defects Institute Team
 
Optic Nerve Hypoplasia Brochure

Success Stories

Ryan Chapman's Story

 

The Eye Birth Defects Institute in The Vision Center at Children's Hospital Los Angeles treats and studies a full spectrum of congenital diseases that result in anatomic abnormalities of the eye and optic nerve, including optic nerve hypoplasia, the leading cause of blindness in infants in the United States. The Eye Birth Defects Institute is the leading research center in the epidemiology and management of this and other devastating eye birth defects.

The Institute is known worldwide for its extensive research program and successful outcomes for children with extraordinary eye disorders. Under the direction of Mark S. Borchert, MD, the Eye Birth Defects Institute collaborates with other organizations and medical professionals in a quest to find answers for complex optic nerve disorders and other pediatric eye conditions.  

We are the leading research center in eye birth defect conditions of:

Health Forum Interview

Optic Nerve Hypoplasia 
(Feature Length:  2:22)
Dr. Mark Borchert discusses the disorder of optic nerve hypoplasia, which has become one of the most common causes of blindness in children. 

Optic Nerve Hypoplasia (ONH) Leadership

The Eye Birth Defects Institute has the largest study in the world on ONH, with more than 200 subjects enrolled in an ongoing prospective study to determine the prenatal and clinical risk factors for adverse outcomes in children.

ONH occurs when a child’s optic nerves fail to develop fully during early pregnancy, resulting in reduced vision or blindness. ONH is now the foremost single cause of blindness and visual impairment in infants in the United States. 


Eye Birth Defects Research

Our commitment to research in the Eye Birth Defects Institute has led to the development of new knowledge about optic nerve hypoplasia, hypopituitarism, septo-optic dysplasia and other epidemic conditions. We are conducting the largest clinical study in the world to determine outcomes and risk factors involved with optic nerve hypoplasia. With more than 200 subjects enrolled, we remain optimistic about the insights we will discover that may lead to improved treatments for these complex diseases.

Current Open Studies

Participate in the ONH Study

English

   

Espanol
 

Find out more about our research activities by viewing the bios of the team members below: